Apoptrol is a biotechnology company developing small molecules for the inhibition of cell death. It focuses on organ transplant, stroke, and neurological disorders such as Alzheimer's and Parkinson's disease. The company also specializes in disorders of the eye such as macular degeneration, retinitis pigmentosa, cataracts, type I diabetes, spinal cord injury, etc.